Work

S4‐04‐06: Dimebon®: A Clinically Promising Drug for Alzheimer's Disease, Regulates Amyloid‐Beta Metabolism in Cultured Cells, In Isolated Nerve Terminals, and In the Interstitial Fluid of the Living Rodent Brain

Year: 2009

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2009.07.133

Authors: Sam Gandy, John Cirrito, John Steele, Soong Ho Kim, Gopal Thinakaran, David Westaway, Paul Fraser, Peter St George Hyslop, Mary Sano, Ilya Bezprozvanny, Michelle E. Ehrlich, David M. Holtzman

Institutions: James J. Peters VA Medical Center, Icahn School of Medicine at Mount Sinai, Washington University in St. Louis, University of Chicago, University of Alberta, University of Toronto, The University of Texas Southwestern Medical Center

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cure Alzheimer's Fund, National Institute on Aging

OpenAlex ID: W1968623426

FWCI: 0.393

Cites:

Cited by: 2

Related to: 10